For a drug with first-order elimination, why is time to reach steady state approximately 4–5 half-lives, and does this change with multiple dosing?

Get ready for the MDC Pharmacokinetics (PK) II Exam. Study with flashcards and multiple choice questions, each offering hints and explanations. Excel in your exam preparation!

Multiple Choice

For a drug with first-order elimination, why is time to reach steady state approximately 4–5 half-lives, and does this change with multiple dosing?

Explanation:
In first-order elimination, the amount of drug in the body decays by a constant fraction each half-life. When you dose repeatedly, the drug from previous doses adds on top of what’s left from before, and the system gradually settles into a repeating pattern. After about four to five half-lives, the amount remaining from earlier doses is quite small (roughly 1/16 to 1/32 of what was peak), so the fluctuations between successive doses become negligible and a steady pattern with the same peaks and troughs repeats each interval. That’s why steady state is reached in about 4–5 half-lives. The time to reach this state is governed by the elimination rate (the half-life) and does not change with how you dose in terms of dose amount or dosing interval; what changes with dosing is how much accumulation occurs, which depends on how the dosing interval compares to the half-life.

In first-order elimination, the amount of drug in the body decays by a constant fraction each half-life. When you dose repeatedly, the drug from previous doses adds on top of what’s left from before, and the system gradually settles into a repeating pattern. After about four to five half-lives, the amount remaining from earlier doses is quite small (roughly 1/16 to 1/32 of what was peak), so the fluctuations between successive doses become negligible and a steady pattern with the same peaks and troughs repeats each interval. That’s why steady state is reached in about 4–5 half-lives.

The time to reach this state is governed by the elimination rate (the half-life) and does not change with how you dose in terms of dose amount or dosing interval; what changes with dosing is how much accumulation occurs, which depends on how the dosing interval compares to the half-life.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy